The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2022

Filed:

May. 02, 2019
Applicants:

Alimera Sciences, Inc., Alpharetta, GA (US);

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Kenneth E. Green, Johns Creek, GA (US);

Peter Campochiaro, Baltimore, MD (US);

Yogita Kanan, Baltimore, MD (US);

Assignees:

Alimera Sciences, Inc., Alpharetta, GA (US);

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/25 (2006.01); A61K 9/00 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/25 (2013.01); A61K 9/0051 (2013.01); A61P 27/02 (2018.01);
Abstract

A method of treating or inhibiting degeneration of a retina of a subject in need thereof comprising administering an effective amount of a compound of metipranolol, or a metabolite thereof, to an organ, a tissue, or the subject, wherein the degeneration of the retina is caused by an ocular disease. In some embodiments, the compound, or a metabolite thereof, is administered topically, orally, or parenterally. In some embodiments, a drug delivery vehicle comprising a dosage of the compound, or the metabolite of, is delivered parenterally via intravitreal injection. In further embodiments, the dosage may range from 0.5 μg/day-15 μg/day.


Find Patent Forward Citations

Loading…